E-Mail
The tuberculosis (TB) vaccine Bacillus Calmette-Guerin (BCG) could protect newborns against a variety of common infections, such as upper respiratory tract infections, chest infections and diarrhoea, according to a new study in
The Lancet Infectious Diseases.
The research is the first of its kind to rigorously investigate the full range of illnesses BCG could protect infants against. It suggests that vaccinating all babies on the day of birth with BCG could reduce neonatal infections and death in areas with high infectious disease rates, potentially saving thousands of lives a year. The results also increase the possibility that the vaccine might be used to protect children and adults against COVID-19 and other new infectious diseases.
Richer countries were more likely to see rates of COVID-19 fall faster during the first wave of the pandemic, according to new research published in the journal Frontiers in Public Health.
E-Mail
IMAGE: Jason Schwalb, M.D., just before surgically implanting the first Vercise Genus™ Deep Brain Stimulation (DBS) System in the United States. view more
Credit: Henry Ford Health System
DETROIT (Feb. 18, 2021) - The Parkinson s Disease and Movement Disorder Center at Henry Ford Health System was the first in the United States to offer a new FDA-approved device to help treat the symptoms of Parkinson s disease. Neurosurgeon Jason Schwalb, M.D. surgically implanted the Vercise Genus™ Deep Brain Stimulation (DBS) System, which stimulates a targeted region of the brain through - implanted leads that are placed in the brain. The leads are powered by a device called an implantable pulse generator, which sits under the skin in the chest. The case was performed at Henry Ford West Bloomfield Hospital.
E-Mail
The COVID-19 pandemic s heavy toll on older Americans highlights the need to strengthen the nation s safety net for people in need of long-term services and supports, an Oregon Health & Science University researcher and co-authors argue in a new report published by
Milbank Quarterly.
The report proposes a system of universal coverage to support the long-term care of all older Americans. This approach would protect against financial catastrophe and end the current system that is based on the need to be financially destitute in order to access coverage via Medicaid, the authors write. Such an approach would benefit both individuals and families and would also create a far more stable and more generous funding stream to providers.
E-Mail
Aurora, Colo. (Feb. 17, 2021) ? The National Institute of Health s (NIH) National Heart, Lung and Blood Institute (NHLBI) is supporting an estimated 3-year, $2.7 million award to the University of Colorado Denver through its Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) initiative to address health disparities in diverse Colorado communities. The overarching goal is to help disadvantaged kids with uncontrolled asthma breathe better.
The DECIPHeR Alliance is composed of seven research centers across the United States plus a research coordinating center. The Colorado DECIPHeR site is made up of team members from Children s Hospital Colorado s (Children s Colorado) Breathing Institute, National Jewish Health, University of Colorado School of Medicine (CUSOM), Colorado Comprehensive School-Centered Asthma Program (AsthmaCOMP), and the Adult and Child Consortium for Health Outcomes Research and Delivery